Loading clinical trials...
Loading clinical trials...
The Effect of HydroCurc™ Curcumin and Ferrous Iron Supplementation on Iron Status and Inflammatory and Neurotrophic Marker Levels in Healthy Adults
INTRODUCTION: Iron is a vital nutrient for many physiological processes including DNA production, oxygen transport and neuronal processes. However, several factors limit iron absorption including: limited bioavailability of iron (dietary or supplementation sources), can be subject to dietary iron inhibitors (e.g. calcium). Excess iron can cause cellular oxidative stress in the body. Curcumin is an active component found in turmeric, known for its anti-oxidant and anti-inflammatory properties. Co-administration of iron and curcumin may influence iron, inflammatory status and/or neurotrophic markers in the body.
Intervention study with five parallel treatment groups in a randomised, double-blind, placebo-controlled design. Study population: Healthy Participants (Male or Female) will receive daily supplements (active or equivalent placebos) for 6 weeks (42 days) Biological samples (blood and urine samples) are collected at baseline visit (day 1), mid-point (day 21) and end-point (day 42). In addition, pertinent questionnaires (Visual Analogue Scale-Fatigue \[VAS-F\] and oral iron supplement questionnaire will be collected at the aforementioned time points.
Age
18 - 40 years
Sex
ALL
Healthy Volunteers
Yes
University of Westminster
London, United Kingdom
Start Date
July 18, 2018
Primary Completion Date
November 11, 2019
Completion Date
January 31, 2020
Last Updated
July 10, 2020
155
ACTUAL participants
Ferrous Sulphate 65 mg
DIETARY_SUPPLEMENT
Curcumin
DIETARY_SUPPLEMENT
Placebo (Ferrous Sulphate)
OTHER
Placebo (Curcumin)
OTHER
Ferrous Sulphate 18mg
DIETARY_SUPPLEMENT
Lead Sponsor
University of Westminster
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05467423